Highsmith, Kaitlin N

Carfilzomib and pomalidomide: recent advances in the treatment of multiple myeloma. [electronic resource] - Pharmacotherapy Sep 2014 - 927-40 p. digital

Publication Type: Journal Article; Review

1875-9114

10.1002/phar.1463 doi


Angiogenesis Inhibitors--adverse effects
Antineoplastic Agents--adverse effects
Humans
Multiple Myeloma--drug therapy
Oligopeptides--adverse effects
Survival Rate
Thalidomide--adverse effects
Treatment Outcome